Chronic obstructive pulmonary disease and chronic heart failure: two muscle diseases?

Journal of Cardiopulmonary Rehabilitation
Thierry TroostersMarc Decramer

Abstract

Chronic obstructive pulmonary disease and congestive heart failure are two increasingly prevalent chronic diseases. Although care for these patients often is provided by different clinical teams, both disease conditions have much in common. In recent decades, more knowledge about the systemic impact of both diseases has become available, highlighting remarkable similarities in terms of prognostic factors and disease management. Rehabilitation programs deal with the systemic consequences of both diseases. Although clinical research also is conducted by various researchers investigating chronic obstructive pulmonary disease and chronic heart failure, it is worthwhile to compare the progress in relation to these two diseases over recent decades. Such comparison, the purpose of the current review, may help clinicians and scientists to learn about progress made in different, yet related, fields. The current review focuses on the similarities observed in the clinical impact of muscle weakness, the mechanisms of muscle dysfunction, the strategies to improve muscle function, and the effects of exercise training on chronic obstructive pulmonary disease and chronic heart failure.

Associated Clinical Trials

References

Sep 1, 1992·Journal of Applied Physiology·J RocaP D Wagner
Apr 1, 1994·The European Respiratory Journal·R E WegnerH Magnussen
Jul 1, 1994·American Journal of Respiratory and Critical Care Medicine·M DecramerP Rogiers
Jan 1, 1996·American Journal of Respiratory and Critical Care Medicine·F MaltaisP LeBlanc
Mar 1, 1996·American Journal of Respiratory and Critical Care Medicine·R GosselinkM Decramer
Jun 1, 1996·American Journal of Respiratory and Critical Care Medicine·M DecramerR Dom
Aug 1, 1996·American Journal of Respiratory and Critical Care Medicine·F MaltaisR Belleau
Oct 1, 1996·The European Respiratory Journal·G StassijnsM Decramer
Feb 1, 1997·The European Respiratory Journal·M DecramerG Evers
Apr 18, 1997·International Journal of Cardiology·A ClarkK Arbuthnott
Jun 1, 1997·European Heart Journal·M SchaufelbergerK Swedberg
Dec 31, 1997·Journal of the American College of Cardiology·D HarringtonA J Coats
Jun 25, 1998·American Journal of Respiratory and Critical Care Medicine·A M ScholsE F Wouters
Aug 12, 1998·American Journal of Respiratory and Critical Care Medicine·S BernardF Maltais
Aug 14, 1998·Journal of Cardiopulmonary Rehabilitation·J F MaillefertJ P Didier
Mar 2, 1999·American Journal of Respiratory and Critical Care Medicine·R S RichardsonP D Wagner
Mar 2, 1999·American Journal of Respiratory and Critical Care Medicine·S BernardF Maltais
Mar 26, 1999·Journal of the American College of Cardiology·V AdamsR Hambrecht
Jun 3, 1999·American Journal of Respiratory and Critical Care Medicine·E SalaP D Wagner
Jun 11, 1999·The American Journal of Cardiology·K MeyerK Schnellbacher
Oct 9, 1999·The European Respiratory Journal·R CoppoolseE F Wouters
Feb 15, 2000·American Journal of Respiratory and Critical Care Medicine·M Jeffery MadorL Pineda
Mar 11, 2000·American Journal of Respiratory and Critical Care Medicine·E C CreutzbergE F Wouters
Dec 6, 2000·International Journal of Cardiology·G S FilippatosG Baltopoulos
Feb 7, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·J S GreiweC F Semenkovich
Mar 29, 2001·Journal of Cardiopulmonary Rehabilitation·T TroostersM Decramer
Apr 12, 2001·European Journal of Clinical Investigation·T GustafssonE Jansson
Apr 18, 2001·The American Journal of Cardiology·D GeorgiouS Glied
Jul 10, 2001·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·G CellaJ Fareed
Oct 24, 2001·American Journal of Respiratory and Critical Care Medicine·R A RabinovichJ Roca
Feb 28, 2002·Duodecim; lääketieteellinen aikakauskirja·J Lommi

❮ Previous
Next ❯

Citations

Apr 25, 2006·Journal of Palliative Medicine·Egidio Del FabbroEduardo Bruera
Mar 25, 2008·Journal of Cardiopulmonary Rehabilitation and Prevention·Isabelle VivodtzevFrançois Maltais
Oct 22, 2010·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Howard J GreenSusan Tupling
Sep 12, 2008·Neuroepidemiology·A S BuchmanD A Bennett
Aug 12, 2009·Critical Care : the Official Journal of the Critical Care Forum·Zudin Puthucheary, Nicholas Hart
Nov 8, 2007·Medicine and Science in Sports and Exercise·Patrick FeiereisenJean Beissel
Apr 5, 2012·Canadian Journal of Physiology and Pharmacology·Howard J GreenSusan Tupling
Aug 10, 2011·Journal of Cardiopulmonary Rehabilitation and Prevention·Rachael A EvansMichael D L Morgan
Oct 16, 2012·Heart Failure Reviews·Cynthia Zizola, P Christian Schulze
Mar 4, 2008·Respiratory Physiology & Neurobiology·J P MattsonR J Isfort
Nov 19, 2011·Chronic Respiratory Disease·Rachael A Evans
Jan 28, 2010·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Michel LamottePhilippe van de Borne
May 26, 2018·COPD·Michele Vitacca, Mara Paneroni
Jun 8, 2013·International Journal of Cardiology·Matthew G D BatesGráinne S Gorman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.